Amplification of the c-met, c-erbB-2 and Epidermal Growth Factor Receptor Gene in Human Gastric Cancers: Correlation to Clinical Features

Publisher： Karger

E-ISSN： 1423-0232|55|5|475-481

ISSN： 0030-2414

Source： Oncology, Vol.55, Iss.5, 1998-08, pp. : 475-481

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Negative Prognostic Impact of the Coexpression of Epidermal Growth Factor Receptor and c-erbB-2 in Locally Advanced Cervical Cancer

By  

Oncology, Vol. 76, Iss. 2, 2009-01 ,pp. : 133-141

Karger

Access to resources Recommend Favorite

ErbB2 Growth Factor Receptor, a Marker for Neuroendocrine Cells?

By  

Pancreatology, Vol. 5, Iss. 1, 2005-04 ,pp. : 44-58

Karger

Access to resources Recommend Favorite

Coexistence of Copy Number Increases of c-Myc, ZNF217, CCND1, ErbB1 and ErbB2 in Ovarian Cancers

By  

Oncology Research and Treatment, Vol. 32, Iss. 7, 2009-06 ,pp. : 405-410

Karger

Access to resources Recommend Favorite

Correlation of ErbB2 Gene Status, mRNA and Protein Expression

By  

Oncology Research and Treatment, Vol. 29, Iss. 6, 2006-06 ,pp. : 246-247

Karger

Access to resources Recommend Favorite

Impact of the 2013 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 (HER2) testing of invasive breast carcinoma: a focus on tumours assessed as ‘equivocal’ for HER2 gene amplification by fluorescence in‐situ hybridization

By  

HISTOPATHOLOGY, Vol. 67, Iss. 6, 2015-12 ,pp. : 880-887

John Wiley & Sons Inc

Access to resources Recommend Favorite